The NCBI Gene Expression Omnibus (GEO) database has revealed that SNX10 is highly expressed in the human liver of NAFLD patients (accession numbers GDS4884, GSE48452) (Fig. S9) 45, 46. Here, SNX10 is linked to metabolic dysfunction-associated steatotic liver disease.